Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oncology (Williston Park). 1999 May;13(5 Suppl 2):25-9.

Managing cancer pain poorly responsive to systemic opioid therapy.

Author information

  • 1Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York, USA.

Abstract

Large surveys of populations with cancer pain indicate that as many as 90% of patients can attain adequate relief of pain using optimal, systemic, opioid-based pharmacotherapy. Skilled clinicians should be able to achieve this benchmark and should also be knowledgeable about the variety of clinical strategies that may be used to manage pain in those patients who are poorly responsive to routine measures. These strategies can be conceptualized in four broad categories: 1) opening the "therapeutic window" by more aggressive side effect management, 2) identifying an opioid with a more favorable balance between analgesia and side effects through "opioid rotation," 3) introducing a pharmacologic technique that reduces the systemic opioid requirement (either treatment with a systemic coanalgesic or a trial of intraspinal therapy), or 4) offering a trial of a nonpharmacologic intervention that may reduce the systemic opioid requirement (e.g., nerve block). In the absence of comparative trials, the selection of a specific approach depends on an informed risk/benefit evaluation based on information from a comprehensive clinical assessment.

PMID:
10356695
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for UBM Medica LLC
    Loading ...
    Write to the Help Desk